Serious adverse drug events reported to the FDA: analysis of the FDA Adverse Event Reporting System 2006 2014 database. | AHRQ Patient Safety Network

Serious adverse drug events reported to the FDA: analysis of the FDA Adverse Event Reporting System 2006 2014 database. | AHRQ Patient Safety Network

• Study
 
• Published July 2018

Serious adverse drug events reported to the FDA: analysis of the FDA Adverse Event Reporting System 2006–2014 database.

Sonawane KB, Cheng N, Hansen RA. J Manag Care Spec Pharm. 2018;24:682-690.

This retrospective study reviewed serious and fatal adverse drug events (ADEs) reported to the Food and Drug Administration between 2006 and 2014. Over the 9-year study period, the number of serious ADEs reported doubled and a small number of medications accounted for a significant number of serious and fatal ADEs.

PubMed citationAvailable at

Related Resources

CASES & COMMENTARIES

The Hidden Harms of Hand Sanitizer

Stephen Stewart, MBChB, PhD

JOURNAL ARTICLE › STUDY

Drug-related harms in hospitalized Medicare beneficiaries: results from the Healthcare Cost and Utilization Project, 2000–2008.

Shamliyan TA, Kane RL. J Patient Saf. 2016;12:89-107.

JOURNAL ARTICLE › STUDY

A cross-sectional observational study of high override rates of drug allergy alerts in inpatient and outpatient settings, and opportunities for improvement.

Slight SP, Beeler PE, Seger DL, et al. BMJ Qual Saf. BMJ Qual Saf 2017;26:217-225.

JOURNAL ARTICLE › STUDY

Patient, physician, medical assistant, and office visit factors associated with medication list agreement.

Reedy AB, Yeh JY, Nowacki AS, Hickner J. J Patient Saf. 2016;12:18-24.

AUDIOVISUAL › IMAGE/POSTER

ADVERSE drug events: incidence and risk reduction across the care continuum.

Wanderer JP, Rathmell JP. Anesthesiology. 2016;124:A23.

View More